e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 28

Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection

Fang He; Huai‐Qiang Ju; Yi Ding; Zhiqiang Jiang; Zhenhui Li; Bo Huang; Xiuhong Wang; Yuanyuan Zhao · 2020 · British Journal of Cancer

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: For patients with locally advanced rectal cancer (LARC), it is unclear whether neoadjuvant chemoradiotherapy-induced pathologic complete response (pCR) individuals would further benefit from adjuvant chemotherapy (ACT). METHODS: The pCR individuals who received different ACT cycles were paired by propensity score matching. Overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) were calculated by Kaplan-Meier and log-rank test. RESULTS: In total, 1041 pCR individuals were identified from 5567 LARC cases.

Abstract by Fang He; Huai‐Qiang Ju; Yi Ding; Zhiqiang Jiang; Zhenhui Li; Bo Huang; Xiuhong Wang; Yuanyuan Zhao, British Journal of Cancer (2020) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41416-020-0989-1